Research findings support the need to establish standards for DFSA care

New toxicology findings reveal the presence of drugs and/or alcohol in 76 per cent of women and men who suspect they were victims of drug-facilitated sexual assault (DFSA). Of those, 64 per cent did not report voluntarily consuming the drugs found, supporting their belief that they may have been slipped a drug. In addition, unexpected male DNA was found in a substantial number of cases, confirming sexual activity.

The study, available at www.sciencedirect.com and to be published in the Journal of Forensic and Legal Medicine builds on previous findings showing that one in five sexual assault victims believe they were drugged prior to the assault, 96 per cent of whom were women.

"Our findings support the need to establish standards for DFSA care that include toxicological and biological testing," says Dr. Janice Du Mont, research scientist, Women's College Research Institute and one of the principal investigators of the study. "We now know that results from such tests can not only lend support to victims' concerns that they were drugged and sexually assaulted but also aid in the identification of substances that may have been used to incapacitate them."

The study, which was funded by Echo: Improving Women's Health in Ontario, an agency of the Ministry of Health and Long-Term Care, involved toxicology and biology screening of women who visited an Ontario Sexual Assault and Domestic Violence Treatment Centre (SADVTC).

"This study not only highlights the importance of testing for drugs in suspected drug-facilitated sexual assaults, but researchers also recommend awareness-raising measures to reduce DFSA in the first place," says Pat Campbell, CEO, Echo. "Echo will support the research team and the care providers to apply these findings to policy and practice."

Toxicology testing on urine samples collected from 178 participants who met criteria for suspected DFSA found drugs and/or alcohol in 135 cases. Sixty-four per cent of those were unexpected - that is, were drugs that had not been reported as having been voluntarily consumed. The most common unexpected substances were street drugs (e.g., cannabinoids, cocaine, amphetamines), analgesics (e.g., codeine, morphine) and anti-anxiety medications (e.g., lorazepam).

Dr. Du Mont notes that "Rohypnol, which has garnered the most attention as a 'date rape drug', was not found in any of the samples." She points out that when it comes to sexual assault "it is critical to understand that a woman incapacitated by drugs or alcohol is not able to consent to sexual activity whether she has consumed the substances voluntarily and/or was slipped a drug."

As part of the study, biological testing was also conducted on vaginal, oral and rectal swabs from 150 cases that met the criteria for suspected DFSA. Male DNA was found in 64 cases; in 47 per cent the finding was unexpected as the client denied having had consensual vaginal/oral/anal intercourse in the week prior to being examined.

"Our advice to women who believe they may be a victim of a drug-facilitated sexual assault is to go to their local sexual assault and domestic violence treatment centre or emergency department as soon as possible," says Sheila Macdonald, co-principal investigator of the study and provincial co-ordinator, SADVTC. "We have a higher chance of identifying unexpected drugs or DNA the sooner a victim is tested."

While many women already safeguard their drinks and use caution when accepting drinks from others, the researchers stress that sexual violence is a societal issue and there is a collective responsibility to intervene whenever possible to prevent sexual assaults from occurring in the first place.

Source: WOMEN'S COLLEGE HOSPITAL

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration